Allergan and tribe to appeal PTAB’s immunity decision

The Saint Regis Mohawk Tribe and Allergan are planning to appeal against the Patent Trial and Appeal Board’s (PTAB) decision rejecting tribal sovereign immunity.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Seven states urge Fed Circuit to rehear tribal immunity case

10 September 2018 Seven states have urged the US Court of Appeals for the Federal Circuit to rehear a decision rejecting the use of tribal sovereign immunity in the inter partes review process.

Americas

Tribal immunity not applicable in IPR, says Fed Circuit

20 July 2018 Allergan and the Saint Regis Mohawk Tribe suffered a blow today as the US Court of Appeals for the Federal Circuit affirmed a decision rejecting use of tribal sovereign immunity in the inter partes review.

Americas

Native American tribe files brief in patent dispute

20 April 2018 The Saint Regis Mohawk Tribe and Allergan have filed a brief in a dispute over whether tribal sovereign immunity can protect patents from the inter partes review (IPR) at the Patent Trial and Appeal Board (PTAB).

More features

Trade secrets go global: How brand owners face a high-stakes battlefront

Killing the golden goose of US drug innovation (Part II): Drug pricing myths

Former pharma GC brings in-house perspective to McGuireWoods

Sandoz eyes US biosimilar launch as Regeneron settles

Killing the golden goose of US drug innovation (Part I): Follow the money

Buchalter brings in new partner to head up medtech

Trump’s march-in rights threat: Why pharma is rethinking collaborations

UK gets new IP minister following cabinet reshuffle

Allergan and tribe to appeal PTAB’s immunity decision

More on this story

Editor's picks

Editor's picks

More features